SITE RESERVED FOR PROFESSIONALS
Level 2 · Controlled trialRandomised controlled trial
Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide
Somekawa Y, Chigughi M, Harada M, Ishibashi T
The Journal of clinical endocrinology and metabolism · 1 August 1999
AUTHORS’ ABSTRACT
The abstract of this article is not reproduced here: its licence does not allow it. It can be read freely on the journal’s website or on Europe PMC.
Scientific information content; it does not replace the advice of a healthcare professional. The presence of a study in this library does not constitute a claim about our products.
← All studies